People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Calistoga Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $60.3M | $850.1M | 2010 |
Langdon Michael Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Langdon Michael Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Topper | 1 | 12 |
| Ed Hurwitz | 1 | 9 |
| Richard Lin | 1 | 8 |
| Carol Gallagher | 1 | 6 |
| Robert Lee Douglas | 1 | 3 |
| W. Michael Gallatin | 1 | 1 |
| James Michael Topper | 1 | 1 |
| Aaron Michael Coe | 1 | 1 |
| Aaron Coe | 1 | 1 |
| Clifford Michael Stocks | 1 | 1 |
| Edward Michael Hurwitz | 1 | 1 |
| Richard Michael Lin | 1 | 1 |
| Andrew Michael Guggenhime | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.